Multiple clinical data for advanced solid tumors of Maiwei Biotech’s “9MW2821” will be announced soon
Introduction: 9MW2821 is Maiwei Biotech’s first site-specific conjugated ADC drug targeting nectin-4. Maiwei Bio announced that it will announce the...